At ET Healthcare, we are dedicated to advancing in vitro diagnostics by improving accuracy, reliability, performance and cost efficiency in clinical lab settings. Using our patented Cyclic Enhanced Fluorescence Assay® (CEFA) technology in combination with our fully automated Pylon™ Immunochemistry Systems, we achieve unparalleled sensitivity (hs-cTnI: 0.5 pg/mL), measurable ranges (ß-hCG: 1.0-300,000 IU/L) and new applications with micro-volume whole blood samples (PCT: 20 µL). ET Healthcare was founded by Dr. Hong Tan and Bob Zuk, two scientist-entrepreneurs with strong track records in clinical diagnostics and life sciences. Throughout their careers, they have been translating groundbreaking inventions into simple, powerful and affordable solutions for clinicians and patients, alike. Headquartered in Palo Alto, California, ET Healthcare synergizes Western innovation with China’s capital efficiency to create high value products for unmet healthcare needs.